MariMed Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MRMD research report →
Companywww.marimedinc.com
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty's Eddies brand; brownies, cookies, and other social sweets under the Bubby's Baked brand; and cannabidiol formulations under the Florance brand.
- CEO
- Jon R. Levine
- IPO
- 2012
- Employees
- 715
- HQ
- Norwood, MA, US
Price Chart
Valuation
- Market Cap
- $27.92M
- P/E
- -2.20
- P/S
- 0.17
- P/B
- 0.57
- EV/EBITDA
- 10.97
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 36.02%
- Op Margin
- -0.57%
- Net Margin
- -7.82%
- ROE
- -23.32%
- ROIC
- -0.64%
Growth & Income
- Revenue
- $159.83M · 1.18%
- Net Income
- $-14,484,000 · -19.07%
- EPS
- $-0.04 · -15.58%
- Op Income
- $-2,068,000
- FCF YoY
- 210.89%
Performance & Tape
- 52W High
- $0.23
- 52W Low
- $0.06
- 50D MA
- $0.08
- 200D MA
- $0.10
- Beta
- 1.34
- Avg Volume
- 647.40K
Get TickerSpark's AI analysis on MRMD
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 20, 26 | Levine Jon R | buy | 40,000 |
| May 7, 26 | Levine Jon R | other | 75,000 |
| May 7, 26 | Levine Jon R | other | 25,988 |
| May 7, 26 | Levine Jon R | other | 75,000 |
| Apr 15, 26 | Shaw Timothy | other | 170,625 |
| Apr 15, 26 | Crandall Ryan | other | 131,250 |
| Apr 15, 26 | Pinho Mario | other | 153,125 |
| Apr 15, 26 | Levine Jon R | other | 122,500 |
| Apr 2, 26 | Shaw Timothy | other | 9,982 |
| Apr 2, 26 | Shaw Timothy | other | 3,459 |
Our MRMD Coverage
We haven't published any research on MRMD yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MRMD Report →